Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug (VVP)
Primary Purpose
Vesico-vaginal Fistula
Status
Completed
Phase
Not Applicable
Locations
Uganda
Study Type
Interventional
Intervention
Surgisis Biodesign (Vesico-vaginal fistula plug)
Sponsored by
About this trial
This is an interventional treatment trial for Vesico-vaginal Fistula focused on measuring fistula, vesico-vaginal fistula
Eligibility Criteria
Inclusion Criteria:
- Patient has signed and dated the informed consent.
- Patient is 18 years old; or is an emancipated minor as defined by Ugandan law or is under 18 but has a parent/guardian who provides informed consent.
- Patient agrees to follow-up schedule.
- Patient presents with a leaking vesico-vaginal fistula, confirmed by exam, with no signs of acute inflammation, no signs of active urinary tract infection that cannot be controlled with a standard pre-operative course of antibiotics, no signs of vaginal infection, or no signs of abscess.
- Patient presents with a fistula of a size and in a location that may be reasonably treated with the VVP device.
Exclusion Criteria:
- Patient is not medically fit enough for surgery under general or spinal anesthesia.
- Patient is a "mature minor" as defined by Ugandan law.
- Patient is pregnant, breastfeeding or planning further pregnancy during the study period.
- Patient has physical allergies or cultural objections to the receipt of porcine products.
- Patient has an active sexually transmitted disease, is HIV-positive, or any other active systemic infection that may interfere with healing.
- Patient has spina bifida or other neural tube defect.
- Patient has interstitial cystitis or other chronic pelvic pain syndrome.
- Patient has signs of acute or chronic pelvic inflammation, active urinary tract infection not responsive to antibiotic treatment, vaginal infection, or abscess of the fistula tract.
- Patient presents with clinically diagnosed sepsis (for whatever reason).
- Patient has concomitant ureterovaginal fistula.
Sites / Locations
- Mbarara University Teaching Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Vesico-vaginal fistula plug
Arm Description
Vesico-vaginal fistula plug
Outcomes
Primary Outcome Measures
Fistula
Adverse Events
Secondary Outcome Measures
Improvement in quality of life
Full Information
NCT ID
NCT00923338
First Posted
June 16, 2009
Last Updated
December 29, 2015
Sponsor
Cook Group Incorporated
1. Study Identification
Unique Protocol Identification Number
NCT00923338
Brief Title
Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug
Acronym
VVP
Official Title
Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug
Study Type
Interventional
2. Study Status
Record Verification Date
July 2012
Overall Recruitment Status
Completed
Study Start Date
September 2009 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
April 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cook Group Incorporated
4. Oversight
5. Study Description
Brief Summary
This clinical trial will study the safety and effectiveness of the Biodesign Vesico-vaginal fistula plug in the treatment of vesico-vaginal fistulas resulting from childbirth trauma.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vesico-vaginal Fistula
Keywords
fistula, vesico-vaginal fistula
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Vesico-vaginal fistula plug
Arm Type
Experimental
Arm Description
Vesico-vaginal fistula plug
Intervention Type
Device
Intervention Name(s)
Surgisis Biodesign (Vesico-vaginal fistula plug)
Other Intervention Name(s)
SurgiSIS Biodesign
Intervention Description
Vesico-vaginal fistula plug
Primary Outcome Measure Information:
Title
Fistula
Time Frame
4 months
Title
Adverse Events
Time Frame
4 months
Secondary Outcome Measure Information:
Title
Improvement in quality of life
Time Frame
4 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient has signed and dated the informed consent.
Patient is 18 years old; or is an emancipated minor as defined by Ugandan law or is under 18 but has a parent/guardian who provides informed consent.
Patient agrees to follow-up schedule.
Patient presents with a leaking vesico-vaginal fistula, confirmed by exam, with no signs of acute inflammation, no signs of active urinary tract infection that cannot be controlled with a standard pre-operative course of antibiotics, no signs of vaginal infection, or no signs of abscess.
Patient presents with a fistula of a size and in a location that may be reasonably treated with the VVP device.
Exclusion Criteria:
Patient is not medically fit enough for surgery under general or spinal anesthesia.
Patient is a "mature minor" as defined by Ugandan law.
Patient is pregnant, breastfeeding or planning further pregnancy during the study period.
Patient has physical allergies or cultural objections to the receipt of porcine products.
Patient has an active sexually transmitted disease, is HIV-positive, or any other active systemic infection that may interfere with healing.
Patient has spina bifida or other neural tube defect.
Patient has interstitial cystitis or other chronic pelvic pain syndrome.
Patient has signs of acute or chronic pelvic inflammation, active urinary tract infection not responsive to antibiotic treatment, vaginal infection, or abscess of the fistula tract.
Patient presents with clinically diagnosed sepsis (for whatever reason).
Patient has concomitant ureterovaginal fistula.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Musa Kayondo, MD
Organizational Affiliation
Mbarara University Teaching Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mbarara University Teaching Hospital
City
Mbarara
Country
Uganda
12. IPD Sharing Statement
Learn more about this trial
Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula Plug
We'll reach out to this number within 24 hrs